Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
08/13/2009 | WO2009074575A3 Organic compounds |
08/13/2009 | WO2008080268A8 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
08/13/2009 | US20090203910 Deprotection of N-BOC compounds |
08/13/2009 | US20090203909 Method and apparatus for the use of [11C] Carbon Monoxide in Labeling Synthesis by Photo-Initiated Carbonylation |
08/13/2009 | US20090203904 Arylsulfinate salts in photoinitiator systems for polymerization reactions |
08/13/2009 | US20090203706 Lysine-based polymeric linkers |
08/13/2009 | US20090203702 INHIBITORS OF p38 |
08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
08/13/2009 | CA2714226A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
08/12/2009 | EP2088143A1 Novel inhibitors of mycobacterium tuberculosis complex cytochrome P450 CYP121 |
08/12/2009 | EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28 |
08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
08/12/2009 | CN101506196A Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses |
08/12/2009 | CN100526301C 1,2-di(cyclic) substituted benzene compounds |
08/11/2009 | US7572911 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility |
08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
08/06/2009 | WO2009096555A1 Method for producing compound having deuterated aromatic ring or heterocyclic ring |
08/06/2009 | WO2009096198A1 Novel biaryl derivative |
08/06/2009 | WO2009095872A2 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
08/06/2009 | WO2009095399A2 Pyrazine derivatives and their use as protein kinase inhbitors |
08/06/2009 | US20090198053 Pyrazine Derivatives and Uses Thereof in Renal Monitoring |
08/06/2009 | US20090197891 Use of (4-Alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease |
08/06/2009 | US20090197888 Fluorinated tripeptide hcv serine protease inhibitors |
08/06/2009 | US20090197065 Birefringent film, production method thereof and use thereof |
08/06/2009 | CA2713553A1 Pyrazine derivatives and their use as protein kinase inhibitors |
08/05/2009 | EP2085390A1 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
08/05/2009 | EP2084138A1 Quinoxaline derivative, and light-emitting element and light-emitting device using quinoxaline derivative |
08/05/2009 | EP1805144A4 Heterocyclical chromophore architectures |
08/05/2009 | EP1473289B1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
08/05/2009 | EP1249233B9 Npyy5 antagonists |
08/05/2009 | EP1186594B1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
08/05/2009 | CN101501008A Arylpiperazine derivatives and uses thereof |
08/05/2009 | CN101500997A PARP inhibitors |
08/05/2009 | CN100522965C 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method |
08/05/2009 | CN100522949C Piperazinedione compounds |
08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
08/04/2009 | US7569691 Protected piperazino group-bearing organoxysilane compound and making method |
08/04/2009 | US7569690 Process for producing oxycarbonyl-substituted piperazine derivative |
08/04/2009 | US7569689 Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
08/04/2009 | CA2568104C Intermediates useful in production of antivirally active heterocyclic azahexane derivatives |
07/30/2009 | US20090192172 2-Alkyl-Cycloalk(en)yl-Carboxamides |
07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
07/30/2009 | US20090191394 Oarganic Compound, Optical Crystal Film and Method of Production Thereof |
07/30/2009 | US20090191227 Compositions and Methods for Enhancing Immune Responses to Vaccines |
07/30/2009 | US20090191125 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process |
07/29/2009 | EP2081912A1 Heterocyclic bridged biphenyls and their use in oleds |
07/29/2009 | EP2081888A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
07/29/2009 | CN101492416A Compounds effecting glucokinase |
07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
07/23/2009 | WO2009091884A1 High dielectric constant liquid crystal |
07/23/2009 | WO2009091014A1 Phenyl acetamide derivative |
07/23/2009 | WO2009042114A3 Phenazine derivatives and uses thereof |
07/23/2009 | WO2009005671A3 Substituted piperazines as cb1 antagonists |
07/23/2009 | US20090186900 Compound |
07/23/2009 | US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists |
07/23/2009 | CA2712948A1 Phenylacetamide derivative |
07/22/2009 | EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
07/22/2009 | CN101490017A Therapeutic piperazines as PDE4 inhibitors |
07/22/2009 | CN101486686A Two compounds with quinoxaline mother ring and preparation thereof |
07/21/2009 | US7563895 Quinoxaline compounds |
07/21/2009 | US7563795 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
07/21/2009 | US7563793 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents |
07/16/2009 | WO2009089234A2 Substituted dibenzhydrylpiperazines |
07/16/2009 | US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications |
07/16/2009 | US20090181967 New compounds I |
07/16/2009 | US20090181951 Parp inhibitors |
07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
07/15/2009 | EP2078720A1 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained and uses thereof |
07/15/2009 | EP2078000A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
07/15/2009 | EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems |
07/15/2009 | EP1805150A4 Heterocyclical chromophore architectures |
07/15/2009 | CN101484430A Theanine derivatives, uses thereof and processes for the manufacture thereof |
07/15/2009 | CN101481357A Preparation of quinoxaline derivatives |
07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
07/14/2009 | US7560463 Diaryl ethers as opioid receptor antagonists |
07/14/2009 | US7560462 Compounds useful for inhibiting CHK1 |
07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
07/14/2009 | CA2335285C Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity |
07/09/2009 | WO2009083532A2 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof |
07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
07/09/2009 | US20090176984 Isotopically Enriched N-Substituted Piperazine Acetic Acids And Methods For The Preparation Thereof |
07/09/2009 | US20090176803 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists |
07/09/2009 | US20090176792 Substituted dibenzhydrylpiperazines |
07/09/2009 | US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
07/08/2009 | EP2076500A1 Phenazine and quinoxaline substituted amino acids and polypeptides |
07/08/2009 | EP2076499A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
07/08/2009 | EP2076494A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
07/08/2009 | EP2076491A1 New benzamide derivatives as bradykinin antagonists |
07/08/2009 | EP2076252A2 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
07/08/2009 | CN100509811C Azaindoles |
07/08/2009 | CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |